Low Evidence
Research Overview
Follistatin Research for Age-Related Muscle Loss
An evidence-based overview of research examining Follistatin in the context of age-related muscle loss. This page synthesizes findings from peer-reviewed literature.
Research Summary
AAV-mediated follistatin overexpression improved muscle and neuromuscular-junction measures in aged mice. A 2026 registry entry for AAV9-FST with or without a VEGF plasmid describes an early human safety study, not an established anti-aging or sarcopenia treatment.
Referenced Studies
Click any PMID to view the full study on PubMed.
Important Disclaimer
This page summarizes research findings and does not constitute medical advice. Always consult a healthcare provider before making health decisions.